Literature DB >> 483189

Serial pulmonary function tests in progressive systemic sclerosis.

L R Bagg, D T Hughes.   

Abstract

Serial pulmonary function tests were performed on nine patients with progressive systemic sclerosis over a mean period of ten years. Abnormality was seen to develop both early and late in the course of the disease, and the earliest abnormality observed was impairment of the transfer factor. Deterioration of some aspect of pulmonary function was noted in each case, evidence of restriction or air trapping being seen with equal frequency. Two patients died, both of causes unrelated to their pulmonary involvement, and even pronounced early involvement of the lungs did not necessarily imply a bad prognosis.

Entities:  

Mesh:

Year:  1979        PMID: 483189      PMCID: PMC471041          DOI: 10.1136/thx.34.2.224

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  15 in total

1.  Pulmonary function in scleroderma. Its relation to changes in the chest roentgenogram and in the skin of the thorax.

Authors:  P K ADHIKARI; F A BIANCHI; S F BOUSHY; A SAKAMOTO; B M LEWIS
Journal:  Am Rev Respir Dis       Date:  1962-12

2.  Respiratory function in progressive systemic sclerosis.

Authors:  M CATTERALL; N R ROWELL
Journal:  Thorax       Date:  1963-03       Impact factor: 9.139

3.  PULMONARY FUNCTION IN SCLERODERMA.

Authors:  B RITCHIE
Journal:  Thorax       Date:  1964-01       Impact factor: 9.139

4.  AN EARLY PULMONARY PHYSIOLOGIC ABNORMALITY IN PROGRESSIVE SYSTEMIC SCLEROSIS (DIFFUSE SCLERODERMA).

Authors:  R J WILSON; G P RODNAN; E D ROBIN
Journal:  Am J Med       Date:  1964-03       Impact factor: 4.965

5.  Scleroderma of the lungs.

Authors:  R D MILLER; W S FOWLER; F H HELMHOLZ
Journal:  Proc Staff Meet Mayo Clin       Date:  1959-02-04

6.  Lung function in patients with systemic sclerosis.

Authors:  D T HUGHES; F I LEE
Journal:  Thorax       Date:  1963-03       Impact factor: 9.139

7.  The effect of age, body size and lung volume change on alveolar-capillary permeability and diffusing capacity in man.

Authors:  M W McGRATH; M L THOMSON
Journal:  J Physiol       Date:  1959-06-11       Impact factor: 5.182

8.  Scleroderma; pulmonary and skin studies before and after treatment with cortisone.

Authors:  A SALOMON; B APPEL; E F DOUGHERTY; J A HERSCHFUS; M S SEGAL
Journal:  AMA Arch Intern Med       Date:  1955-01

9.  Scleroderma: relation of pulmonary changes to esophageal disease.

Authors:  P R MAHRER; J A EVANS; I STEINBERG
Journal:  Ann Intern Med       Date:  1954-01       Impact factor: 25.391

10.  The pulmonary manifestations of scleroderma; an anatomic-physiological correlation.

Authors:  D M SPAIN; A G THOMAS
Journal:  Ann Intern Med       Date:  1950-01       Impact factor: 25.391

View more
  6 in total

1.  The single-breath carbon monoxide transfer test 25 years on: a reappraisal. 2--Clinical considerations.

Authors:  C Ogilvie
Journal:  Thorax       Date:  1983-01       Impact factor: 9.139

2.  Clinical characteristics associated with small airways disease in systemic sclerosis.

Authors:  Sanskriti Varma; Jae Hee Yun; John S Kim; Anna J Podolanczuk; Nina M Patel; Elana J Bernstein
Journal:  J Scleroderma Relat Disord       Date:  2022-03-20

3.  Early pulmonary disease in systemic sclerosis: a comparison between carbon monoxide transfer factor and static lung compliance.

Authors:  A Scheja; A Akesson; P Wollmer; F A Wollheim
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

4.  Imaging of pulmonary disease in scleroderma with J001X scintigraphy.

Authors:  P Diot; E Diot; E Lemarie; J L Guilmot; J L Baulieu; E Asquier; C Valat; A Delarue; A Le Pape
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

5.  High resolution computed tomography in systemic sclerosis. Real diagnostic utilities in the assessment of pulmonary involvement and comparison with other modalities of lung investigation.

Authors:  A Pignone; M Matucci-Cerinic; A Lombardi; R Fedi; R Fargnoli; R De Dominicis; M Cagnoni
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

6.  Lung function abnormalities and decline of spirometry in scleroderma: an overrated danger?

Authors:  M J Abramson; A J Barnett; G O Littlejohn; M M Smith; S Hall
Journal:  Postgrad Med J       Date:  1991-07       Impact factor: 2.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.